The purpose of this study is to measure improvements in liver fibrosis and inflammation with GSK4532990 compared with placebo in participants with NASH and advanced (F3) fibrosis.
Thank you for your interest, but this study is recruiting by invitation only.
North Carolina (Statewide)
A Barritt
Center for Gastrointestinal Biology and Disease
Clinical or Medical
Interventional
Eating, Nutrition, and Metabolism
Kidneys and Liver
Obesity
23-0427
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
